European-based private market firms 'growing and flourishing'
Permira Executive Chairman Kurt Björklund says a European base has proven incredibly valuable as firms look to capitalise on investment opportunities across the continent
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
High Growth Tech Stocks To Watch In Global Markets
Global markets have experienced a positive momentum recently, with U.S. stock indexes climbing for the second consecutive week, led by small-cap stocks and a strong performance in the information technology sector driven by optimism around AI-related advancements. In this context, investors often look for high growth tech stocks that demonstrate resilience and innovation, particularly those that can capitalize on emerging trends like artificial intelligence to potentially drive future growth amidst evolving market conditions. Name Revenue Growth Earnings Growth Growth Rating Shengyi Electronics 22.99% 35.16% ★★★★★★ Shanghai Huace Navigation Technology 24.44% 23.48% ★★★★★★ Intellego Technologies 30.80% 45.66% ★★★★★★ KebNi 21.51% 66.96% ★★★★★★ Pharma Mar 29.61% 44.92% ★★★★★★ eWeLLLtd 24.95% 24.40% ★★★★★★ Global Security Experts 20.56% 28.04% ★★★★★★ Rakovina Therapeutics 40.75% 16.49% ★★★★★★ Elliptic Laboratories 36.33% 78.99% ★★★★★★ JNTC 54.24% 87.93% ★★★★★★ Click here to see the full list of 746 stocks from our Global High Growth Tech and AI Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Sectra AB (publ) is a company that offers solutions in the medical IT and cybersecurity sectors across Sweden, the United Kingdom, the Netherlands, and other parts of Europe, with a market capitalization of approximately SEK67.82 billion. Operations: Revenue for Sectra primarily comes from its Imaging IT Solutions and Secure Communications segments, contributing SEK2.80 billion and SEK407 million respectively. The company's focus on medical IT and cybersecurity solutions positions it within key European markets including Sweden, the UK, and the Netherlands. Sectra, a leader in cybersecurity and medical imaging IT, is demonstrating robust financial and strategic growth. In the fiscal year ending April 2025, the company reported a significant revenue increase to SEK 3.54 billion from SEK 3.04 billion the previous year, with net income rising to SEK 563.37 million from SEK 428.39 million. This performance is underpinned by a strong R&D focus, as evidenced by their latest innovations in enterprise imaging solutions provided as cloud services—Sectra One Cloud and Sectra Amplifier Service—which enhance scalability and integrate AI seamlessly into clinical workflows. These advancements not only solidify Sectra's market position but also cater to evolving customer needs in healthcare technology, ensuring continued growth in a competitive landscape. Navigate through the intricacies of Sectra with our comprehensive health report here. Explore historical data to track Sectra's performance over time in our Past section. Simply Wall St Growth Rating: ★★★★★☆ Overview: Wuxi Taclink Optoelectronics Technology Co., Ltd. specializes in the development and production of optoelectronic devices, with a market capitalization of approximately CN¥9.67 billion. Operations: The company focuses on producing optoelectronic devices, contributing significantly to its revenue. Its cost structure and financial performance are primarily driven by this core business area. The company's gross profit margin exhibits notable trends, reflecting its operational efficiency in the market. Wuxi Taclink Optoelectronics Technology is distinguishing itself in the optoelectronics sector with a promising growth trajectory, evidenced by an anticipated 39.1% annual revenue increase and a forecasted 44.1% rise in earnings per year. This performance is bolstered by strategic R&D investments, crucial for sustaining innovation and competitiveness within this high-tech industry. Recent corporate activities, including a significant stock split announced for May 2025, reflect the company's proactive approach to enhancing shareholder value and market presence. These developments underscore Wuxi Taclink's potential to capitalize on expanding market demands while continuously evolving its technological capabilities. Dive into the specifics of Wuxi Taclink Optoelectronics Technology here with our thorough health report. Learn about Wuxi Taclink Optoelectronics Technology's historical performance. Simply Wall St Growth Rating: ★★★★★★ Overview: Fositek Corp. specializes in the manufacture and wholesale of electronic materials and components, with a market capitalization of approximately NT$45.18 billion. Operations: The company generates revenue primarily from electronic components and parts, totaling NT$8.73 billion. Fositek's recent performance and strategic decisions underscore its potential within the high-tech sector. With a 75.3% surge in earnings over the past year, outpacing the industry's 14.2%, and an expected annual revenue growth of 26.7%, Fositek is advancing rapidly. The company has also demonstrated a strong commitment to innovation, as evidenced by its R&D investments which are crucial for maintaining competitiveness in technology-driven markets. Moreover, significant corporate actions like amendments to the Articles of Incorporation reflect a proactive stance in governance that could further bolster investor confidence and business resilience. Click here to discover the nuances of Fositek with our detailed analytical health report. Review our historical performance report to gain insights into Fositek's's past performance. Take a closer look at our Global High Growth Tech and AI Stocks list of 746 companies by clicking here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OM:SECT B SHSE:688205 and TWSE:6805. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
14 minutes ago
- Yahoo
European Penny Stocks Under €2B Market Cap: 3 Hidden Gems To Watch
As the European markets experience a boost with the pan-European STOXX Europe 600 Index rising by 0.90% amid slowing inflation and easing ECB monetary policy, investors are exploring opportunities in less conventional areas. Though 'penny stocks' might sound like a relic from past trading days, they still offer relevant opportunities for those interested in smaller or newer companies. With strong financials, these stocks can provide a mix of affordability and growth potential, making them an intriguing option for investors seeking hidden value. Name Share Price Market Cap Financial Health Rating KebNi (OM:KEBNI B) SEK1.832 SEK496.76M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.66 SEK274.45M ★★★★★★ Cellularline (BIT:CELL) €3.18 €67.07M ★★★★★☆ Fondia Oyj (HLSE:FONDIA) €4.65 €17.39M ★★★★★★ Abak (WSE:ABK) PLN4.20 PLN11.32M ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) SEK2.415 SEK2.31B ★★★★☆☆ Hifab Group (OM:HIFA B) SEK3.60 SEK219.02M ★★★★★★ Euroland Société anonyme (ENXTPA:MLERO) €3.26 €9.49M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.20 €303.74M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.976 €32.68M ★★★★★★ Click here to see the full list of 446 stocks from our European Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Deceuninck NV is involved in the design, manufacture, recycling, and distribution of multi-material window, door, and building solutions across Europe, North America, Turkey, and other international markets with a market cap of €303.74 million. Operations: The company's revenue is primarily generated from its Window and Door Systems segment at €759.81 million, followed by Home Protection at €40.48 million, and Outdoor Living at €26.70 million. Market Cap: €303.74M Deceuninck NV, with a market cap of €303.74 million, shows promising financial health for a penny stock. Its earnings have grown significantly by 46.6% over the past year, outpacing the industry average and its five-year growth rate of 5.1%. The company's interest payments are well covered by EBIT at 9.8x coverage, and its net debt to equity ratio is satisfactory at 16.7%. While Deceuninck's return on equity is low at 4.5%, it trades below fair value estimates by approximately 24.8%. Recent dividend announcements affirm a cash dividend of €0.056 per share payable in May 2025. Jump into the full analysis health report here for a deeper understanding of Deceuninck. Learn about Deceuninck's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Metsä Board Oyj operates in the folding boxboard, fresh fibre linerboard, and market pulp sectors both in Finland and internationally, with a market cap of €1.24 billion. Operations: The company generates €1.94 billion in revenue from its operations in the folding boxboard, fresh fibre linerboard, and market pulp sectors. Market Cap: €1.24B Metsä Board Oyj, with a market cap of €1.24 billion, presents a mixed profile for investors in the penny stock segment. The company's net debt to equity ratio is satisfactory at 20.6%, and its short-term assets exceed both short-term and long-term liabilities, indicating sound liquidity management. However, the return on equity remains low at 1%, and recent earnings show a net loss of €7 million compared to last year's profit. Despite negative earnings growth over the past year, Metsä Board trades significantly below estimated fair value and has recently issued green bonds worth €200 million to finance sustainable projects. Click to explore a detailed breakdown of our findings in Metsä Board Oyj's financial health report. Review our growth performance report to gain insights into Metsä Board Oyj's future. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Xbrane Biopharma AB is a biotechnology company focused on developing, manufacturing, and selling biosimilars, with a market capitalization of SEK413.69 million. Operations: Xbrane Biopharma generates revenue from its Biosimilar Development segment, totaling SEK277.89 million. Market Cap: SEK413.69M Xbrane Biopharma, with a market cap of SEK413.69 million, offers an intriguing yet volatile opportunity in the penny stock landscape. Despite being unprofitable and facing increased volatility, Xbrane has shown significant revenue growth, reporting SEK93.24 million in Q1 2025 compared to SEK14.07 million a year prior. The company's recent follow-on equity offering of SEK200 million aims to bolster its cash runway beyond the current two months. While auditor concerns about its going concern status persist, strategic advancements like the FDA review for its biosimilar candidate could potentially influence future prospects if approvals are secured by October 2025. Click here to discover the nuances of Xbrane Biopharma with our detailed analytical financial health report. Explore Xbrane Biopharma's analyst forecasts in our growth report. Take a closer look at our European Penny Stocks list of 446 companies by clicking here. Want To Explore Some Alternatives? AI is about to change healthcare. These 22 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTBR:DECB HLSE:METSB and OM:XBRANE. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
All Seas Capital Exits G3
Realisation follows significant growth with headcount doubling and international expansion LONDON, June 11, 2025--(BUSINESS WIRE)--All Seas Capital, a pan-European private capital fund that provides transformational capital solutions to leading founder- and entrepreneur-owned companies, is pleased to announce the full realisation of its investment in G3 ("G3" or "the Company"), a global strategic advisory consultancy. As part of the transaction, Oakley Capital Fund VI has acquired a majority stake in the Company. G3 helps clients manage their risk and enable opportunities by providing reputational and strategic intelligence, dispute advice and cyber consulting. The company's clients include some of the largest private equity and sovereign wealth funds, global corporates and leading law firms. Since investing in G3 in 2022, All Seas Capital has partnered closely with the management team to accelerate its expansion strategies. G3 has grown significantly, with headcount more than doubling and global business development capabilities strengthened, with the opening of new offices in New York, Singapore, Tokyo, and Abu Dhabi. All Seas Capital provides flexible long-term capital solutions to leading Western European mid-market businesses. Alongside transformational capital, the firm provides board-level expertise to entrepreneurs and management teams who do not want to sell majority stakes. All Seas Capital is led by Marc Ciancimino and Cristobal Cuart, who co-founded and led KKR's European mezzanine and preferred equity business and have an extensive track record, with €3.4bn invested across 45 businesses prior to founding All Seas Capital. Marc Ciancimino and Cristobal Cuart, Co-Founders and Managing Partners of All Seas Capital, commented: "Since partnering with G3 three years ago, we have worked hard to support its highly capable management team to accelerate its expansion strategies and develop the business. It has achieved great success, capitalising on the significant growth in demand for strategic risk advisory services. At All Seas Capital, we provide flexible, hybrid non-control capital to established founder- and entrepreneur-owned businesses that have already reached scale and can benefit from our support and capital. G3 is a great example of how our approach can support that journey, and we wish the team every success with their new partners at Oakley Capital." All Seas Capital was advised by King & Spalding. G3 was advised by Jefferies, White & Case. LEK and KPMG. About All Seas Capital All Seas Capital is a pan-European private capital firm. We partner with mid-market businesses, constructing flexible, structured capital solutions - investing a combination of debt and equity - to empower transformational growth. The team is led by Marc Ciancimino and Cristobal Cuart who co-founded and led KKR's European mezzanine and preferred equity business. We back growing businesses with strong management teams and help them accelerate their growth plans, supporting entrepreneur and family-owned businesses who have already reached profitability but need strategic capital to realise their ambitions. These businesses have underlying resilience, typically generating EBITDA of €5-50m, with our investment ranging from €30-100m. About G3 G3 is a global advisory firm that helps clients manage risk and make better business decisions. We provide intelligence that enables our clients to make informed decisions on deals, partnerships, new markets, and regulatory and political environments. We offer investigations and dispute advice to support legal strategies and recover assets. We deliver cyber-security advice to defend against today's prevailing threat environment. Our clients include FTSE and Fortune 500 corporations, sovereign wealth and pension funds, private equity firms, and leading international law firms. Founded over twenty years ago, G3 has an established global platform and operates in most geographies worldwide. Our multidisciplinary team is drawn from government, finance, law, consultancy, and law enforcement. We are headquartered in London, with offices in the US, the Middle East, and Asia. View source version on Contacts For further information, please contact: All Seas CapitalCharlotte Balbirnie+44 7989 528421CBalbirnie@
